Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.01 USD | -0.81% | -6.93% | +27.14% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.14% | 2.28B | |
+14.43% | 3,197B | |
+14.18% | 89.6B | |
+8.75% | 80.08B | |
-13.37% | 55.52B | |
+22.60% | 46.79B | |
+32.14% | 46.34B | |
-30.71% | 43.95B | |
+71.93% | 41.34B | |
-2.58% | 26.5B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- William Blair Downgrades Cellebrite DI to Market Perform From Outperform